Raymund Razonable to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Raymund Razonable has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
1.493
-
An update on Mycobacterium tuberculosis infection after hematopoietic stem cell transplantation in adults. Clin Transplant. 2018 12; 32(12):e13430.
Score: 0.278
-
Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation. Curr Opin Infect Dis. 2018 08; 31(4):286-291.
Score: 0.273
-
Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia. Clin Transplant. 2018 01; 32(1).
Score: 0.261
-
Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients. Expert Rev Mol Diagn. 2017 07; 17(7):633-639.
Score: 0.251
-
Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients1. Emerg Infect Dis. 2017 03; 23(3):510-512.
Score: 0.247
-
Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation. Expert Rev Clin Pharmacol. 2018 Aug; 11(8):773-788.
Score: 0.068
-
New Developments in the Management of Cytomegalovirus Infection After Transplantation. Drugs. 2018 Jul; 78(11):1085-1103.
Score: 0.068
-
A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2013 Oct; 15(5):487-92.
Score: 0.048